Latest Cooper Companies quarterly has quite a bit of commentary on Misight and interest from analysts in the myopia market. Some of the highlights:
- Quarterly revenue for Misight now US$24M (below is the revenue statement)
- Misight starting to take business from the Ortho-K offerings - suggests parents like soft contact lenses more than the overnight option
- Europe is picking up
- Being the only FDA approved product is very important to them.
Misight will clearly generate greater than US$100M in revenue for 2024. Just imagine what a better product could do once FDA approval is gained.
Latest Cooper Companies quarterly has quite a bit of commentary...
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.010(6.90%) |
Mkt cap ! $7.392M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 12.0¢ | $17.5K | 138.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8331 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 15.41pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
14.5¢ |
Change
-0.010 ( 9.38 %) |
||||
| Open | High | Low | Volume | ||
| 15.5¢ | 16.0¢ | 14.5¢ | 10433 | ||
| Last updated 14.59pm 26/04/2024 ? | |||||
| VTI (ASX) Chart |